FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023753181> ?p ?o ?g. }

• W2023753181 endingPage "373" @default.
• W2023753181 startingPage "364" @default.
• W2023753181 abstract "Women classified as having triple-negative tumors have a poor prognosis. The importance of CD44+/CD24−/low (stem/progenitor cell-phenotype) in breast cancer patients has also been appreciated. However, correlation between triple negativity and CD44+/CD24−/low with tumor recurrence remains elusive. In the present study, we evaluated tumor specimens of 50 breast cancer patients with known hormone receptor status for whom we had follow-up information and outcome data available, and performed immunohistochemistry analysis to determine CD44 and CD24 expression. Gene expression arrays were also independently performed on 52 breast cancer specimens with banked frozen tissue. Lastly, we used FVBN202 transgenic mouse model of breast carcinoma and determined the hormone receptor status, the proportion of CD44+/CD24−/low breast cancer stem-like cells, and the behavior of the tumor. We determined that patients with triple-negative tumors had significantly higher incidence of recurrence or distant metastasis associated with increased frequency of breast cancer stem cell phenotypes compared with those with non–triple-negative tumors. Preclinical studies in FVBN202 transgenic mice confirmed these findings by showing that relapsed tumors were triple negative and had significantly higher frequency of breast cancer stem cells compared with their related primary tumors. Unlike non–triple-negative primary tumors, relapsed triple-negative tumors were tumorigenic at low doses when inoculated into FVBN202 transgenic mice. These findings suggest that CD44+/CD24−/low breast cancer stem-like cells play an important role in the clinical behavior of triple-negative breast cancer and that development of therapeutic targets directed to breast cancer stem-like cells may lead to reduction in the aggressiveness of triple-negative breast cancers." @default.
• W2023753181 created "2016-06-24" @default.
• W2023753181 creator A5018922167 @default.
• W2023753181 creator A5020110586 @default.
• W2023753181 creator A5024340698 @default.
• W2023753181 creator A5043967154 @default.
• W2023753181 creator A5074048193 @default.
• W2023753181 creator A5076049316 @default.
• W2023753181 creator A5078225240 @default.
• W2023753181 date "2012-03-01" @default.
• W2023753181 modified "2023-10-18" @default.
• W2023753181 title "CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome" @default.
• W2023753181 cites W1775510084 @default.
• W2023753181 cites W1894632965 @default.
• W2023753181 cites W1965124339 @default.
• W2023753181 cites W1973968998 @default.
• W2023753181 cites W1976203623 @default.
• W2023753181 cites W1982093899 @default.
• W2023753181 cites W1996014355 @default.
• W2023753181 cites W2009218955 @default.
• W2023753181 cites W2018022325 @default.
• W2023753181 cites W2022664855 @default.
• W2023753181 cites W2023427658 @default.
• W2023753181 cites W2030582688 @default.
• W2023753181 cites W2051741566 @default.
• W2023753181 cites W2053340170 @default.
• W2023753181 cites W2055853764 @default.
• W2023753181 cites W2056025993 @default.
• W2023753181 cites W2060523101 @default.
• W2023753181 cites W2085134335 @default.
• W2023753181 cites W2095156669 @default.
• W2023753181 cites W2095510030 @default.
• W2023753181 cites W2102085111 @default.
• W2023753181 cites W2105381419 @default.
• W2023753181 cites W2106619332 @default.
• W2023753181 cites W2107277218 @default.
• W2023753181 cites W2109972881 @default.
• W2023753181 cites W2117025824 @default.
• W2023753181 cites W2117267351 @default.
• W2023753181 cites W2123558100 @default.
• W2023753181 cites W2129067399 @default.
• W2023753181 cites W2130363647 @default.
• W2023753181 cites W2131596261 @default.
• W2023753181 cites W2138240181 @default.
• W2023753181 cites W2141393790 @default.
• W2023753181 cites W2155745102 @default.
• W2023753181 cites W2159640574 @default.
• W2023753181 cites W2163292580 @default.
• W2023753181 doi "https://doi.org/10.1016/j.humpath.2011.05.005" @default.
• W2023753181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21835433" @default.
• W2023753181 hasPublicationYear "2012" @default.
• W2023753181 type Work @default.
• W2023753181 sameAs 2023753181 @default.
• W2023753181 citedByCount "221" @default.
• W2023753181 countsByYear W20237531812012 @default.
• W2023753181 countsByYear W20237531812013 @default.
• W2023753181 countsByYear W20237531812014 @default.
• W2023753181 countsByYear W20237531812015 @default.
• W2023753181 countsByYear W20237531812016 @default.
• W2023753181 countsByYear W20237531812017 @default.
• W2023753181 countsByYear W20237531812018 @default.
• W2023753181 countsByYear W20237531812019 @default.
• W2023753181 countsByYear W20237531812020 @default.
• W2023753181 countsByYear W20237531812021 @default.
• W2023753181 countsByYear W20237531812022 @default.
• W2023753181 countsByYear W20237531812023 @default.
• W2023753181 crossrefType "journal-article" @default.
• W2023753181 hasAuthorship W2023753181A5018922167 @default.
• W2023753181 hasAuthorship W2023753181A5020110586 @default.
• W2023753181 hasAuthorship W2023753181A5024340698 @default.
• W2023753181 hasAuthorship W2023753181A5043967154 @default.
• W2023753181 hasAuthorship W2023753181A5074048193 @default.
• W2023753181 hasAuthorship W2023753181A5076049316 @default.
• W2023753181 hasAuthorship W2023753181A5078225240 @default.
• W2023753181 hasConcept C118646709 @default.
• W2023753181 hasConcept C121608353 @default.
• W2023753181 hasConcept C126322002 @default.
• W2023753181 hasConcept C142724271 @default.
• W2023753181 hasConcept C143998085 @default.
• W2023753181 hasConcept C1491633281 @default.
• W2023753181 hasConcept C2779013556 @default.
• W2023753181 hasConcept C2779492189 @default.
• W2023753181 hasConcept C2780110267 @default.
• W2023753181 hasConcept C2780932548 @default.
• W2023753181 hasConcept C28328180 @default.
• W2023753181 hasConcept C3018521938 @default.
• W2023753181 hasConcept C502942594 @default.
• W2023753181 hasConcept C530470458 @default.
• W2023753181 hasConcept C54355233 @default.
• W2023753181 hasConcept C55427017 @default.
• W2023753181 hasConcept C71924100 @default.
• W2023753181 hasConcept C86803240 @default.
• W2023753181 hasConceptScore W2023753181C118646709 @default.
• W2023753181 hasConceptScore W2023753181C121608353 @default.
• W2023753181 hasConceptScore W2023753181C126322002 @default.
• W2023753181 hasConceptScore W2023753181C142724271 @default.
• W2023753181 hasConceptScore W2023753181C143998085 @default.
• W2023753181 hasConceptScore W2023753181C1491633281 @default.

• next